Onodera M - Search Results

1

Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.

Onodera M, Nelson DM, Sakiyama Y, Candotti F, Blaese RM. Onodera M, et al. Acta Haematol. 1999;101(2):89-96. doi: 10.1159/000040930. Acta Haematol. 1999. PMID: 10202239 Review.

2

Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.

Onodera M, Ariga T, Kawamura N, Kobayashi I, Ohtsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity GJ, Blaese RM, Sakiyama Y. Onodera M, et al. Blood. 1998 Jan 1;91(1):30-6. Blood. 1998. PMID: 9414266 Free article. Clinical Trial.

3

Development of improved adenosine deaminase retroviral vectors.

Onodera M, Nelson DM, Yachie A, Jagadeesh GJ, Bunnell BA, Morgan RA, Blaese RM. Onodera M, et al. J Virol. 1998 Mar;72(3):1769-74. doi: 10.1128/JVI.72.3.1769-1774.1998. J Virol. 1998. PMID: 9499026 Free PMC article.

4

Retroviral-mediated transfer and expression of the common gamma chain into human hematopoietic progenitors.

Candotti F, Onodera M, Knazek RA, Blaese RM. Candotti F, et al. Among authors: onodera m. Acta Haematol. 1999;101(2):106-10. doi: 10.1159/000040932. Acta Haematol. 1999. PMID: 10202241

5

Adenosine deaminase deficiency as the first target disorder in gene therapy.

Onodera M, Sakiyama Y. Onodera M, et al. Expert Opin Investig Drugs. 2000 Mar;9(3):543-9. doi: 10.1517/13543784.9.3.543. Expert Opin Investig Drugs. 2000. PMID: 11060694 Review.

6

Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.

Otsu M, Yamada M, Nakajima S, Kida M, Maeyama Y, Hatano N, Toita N, Takezaki S, Okura Y, Kobayashi R, Matsumoto Y, Tatsuzawa O, Tsuchida F, Kato S, Kitagawa M, Mineno J, Hershfield MS, Bali P, Candotti F, Onodera M, Kawamura N, Sakiyama Y, Ariga T. Otsu M, et al. Among authors: onodera m. J Clin Immunol. 2015 May;35(4):384-98. doi: 10.1007/s10875-015-0157-1. Epub 2015 Apr 15. J Clin Immunol. 2015. PMID: 25875699

7

Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy.

Otsu M, Hershfield MS, Tuschong LM, Muul LM, Onodera M, Ariga T, Sakiyama Y, Candotti F. Otsu M, et al. Among authors: onodera m. Hum Gene Ther. 2002 Feb 10;13(3):425-32. doi: 10.1089/10430340252792558. Hum Gene Ther. 2002. PMID: 11860709

8

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. Okada T, et al. Among authors: onodera m. J Gene Med. 2004 Mar;6(3):288-99. doi: 10.1002/jgm.490. J Gene Med. 2004. PMID: 15026990

9

A simple and reliable method for screening retroviral producer clones without selectable markers.

Onodera M, Yachie A, Nelson DM, Welchlin H, Morgan RA, Blaese RM. Onodera M, et al. Hum Gene Ther. 1997 Jul 1;8(10):1189-94. doi: 10.1089/hum.1997.8.10-1189. Hum Gene Ther. 1997. PMID: 9215736

10

Overexpression of retinoic acid receptor alpha suppresses myeloid cell differentiation at the promyelocyte stage.

Onodera M, Kunisada T, Nishikawa S, Sakiyama Y, Matsumoto S, Nishikawa S. Onodera M, et al. Oncogene. 1995 Oct 5;11(7):1291-8. Oncogene. 1995. PMID: 7478549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters